Consumer-products company Helen of Troy can still hold its fiscal 2027 outlook, according to UBS, but the bigger question is whether sales can reaccelerate. Even as tariff refunds and easing input costs may help near-term profits, the path for revenue remains unclear.
What UBS Expects
UBS, a global investment bank, expects fiscal first-quarter earnings of $0.01 per share, slightly above Helen of Troy's own roughly breakeven view. For the full fiscal 2027 year, UBS forecasts adjusted earnings of $3.55 per share, which falls within management's guidance range of $3.25 to $3.75.
The shaky part is revenue. UBS models just 0.3% organic sales growth in fiscal Q1, with the Home & Outdoor segment up 6% but Beauty & Wellness down 5%. And it expects sales to run a bit stronger in the first half of fiscal 2027, then soften in the second half.
Cost relief could still matter. UBS points to potential tariff refunds and less pressure from commodities, which can lift earnings when growth is thin. But when the sales line is hard to predict, investors tend to treat profits as lower-quality and apply a lower valuation multiple, which helps explain UBS's neutral stance and $25 price target.
What It Means for Investors
UBS's $25 target on $3.55 of fiscal 2027 EPS implies a price-to-earnings multiple of about 7 times. That math is the signal: UBS isn't paying up for the outlook, even though it sees earnings landing within management's range. When a company's sales path is unclear, markets usually demand a bigger cushion, because small swings in demand can quickly change margins and make guidance less believable.
So, while tariff refunds and easing costs could help results in the near term, the next few revenue updates are likely to matter more for any sustained re-rating. In other words, improving demand would do more to lift the valuation than incremental cost wins.
For everyday investors, this story highlights a key lesson: earnings guidance alone isn't enough. When a company's sales growth is uncertain, the market often discounts even solid profit forecasts. That's why Helen of Troy's stock trades at a low multiple, and why investors should watch upcoming quarterly reports for signs of a demand pickup.
In the broader market context, similar dynamics are playing out across sectors. For example, Broadcom's chip deal with Apple through 2031 shows how clear revenue visibility can support valuations, while European stocks slipped recently as tech and oil shares cooled, reflecting the market's sensitivity to growth signals.
Bottom Line
Helen of Troy's ability to hold its fiscal 2027 outlook is a positive sign, but the real test will be whether sales can reaccelerate. Until then, the stock's low valuation reflects the market's caution. Investors should keep an eye on the company's next few revenue reports for any signs of a turnaround.
